Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short‐term vs long‐term survivors of glioblastoma
Paula Ofek(Tel Aviv University), Ronit Satchi‐Fainaro(Tel Aviv University)
Cited by 9
Related Papers
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer
|Nature Communications|2017|98
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression
|Nature Communications|2021|78